【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Market Research Methodology
04.1 Market research process
04.2 Research methodology
05.Introduction
06.Disease Overview: Crohn’s Disease
06.1 Understanding the disease
06.2 Etiology
06.2.1 Autoimmune reaction
06.2.2 Genes
06.2.3 Environment
06.3 Stages of Crohn’s disease
06.4 Epidemiology
06.4.1 Worldwide prevalence of Crohn’s disease
06.4.2 US
06.4.3 UK
06.5 Symptoms
06.5.1 Diarrhea
06.5.2 Fever and fatigue
06.5.3 Abdominal pain and cramping
06.5.4 Perianal disease and blood in stool
06.5.5 Reduced appetite and weight loss
06.6 Diagnosis and testing
06.6.1 Early tests and exams
06.6.2 Endoscopy and biopsy
06.6.3 Chromoendoscopy
06.6.4 Small intestinal imaging
06.7 Treatment
06.7.1 Medication
06.7.2 Diet and nutrition
06.7.3 Surgery
07.Disease Overview: Ulcerative Colitis
07.1 Understanding the disease
07.2 Etiology
07.2.1 Autoimmune reaction
07.2.2 Genetics
07.2.3 Environmental factors
07.3 Prognosis
07.4 Epidemiology
07.4.1 Global
07.4.2 UK
07.4.3 US
07.5 Symptoms
07.6 Diagnosis and testing
07.7 Treatment
07.7.1 Medical treatment options
07.7.2 Surgical procedures
08.Pipeline Portfolio
08.1 Crohn’s disease pipeline landscape
08.1.1 Some emerging therapeutic options
08.2 Ulcerative colitis pipeline landscape
09.Market Landscape
09.1 Global inflammatory bowel disease market
09.2 Market size and forecast
09.3 Inflammatory bowel disease market in US
09.3.1 Market size and forecast
09.4 Inflammatory bowel disease market in EU
09.4.1 Market size and forecast
09.5 Inflammatory bowel disease market in Japan
09.5.1 Market size and forecast
09.6 Five forces analysis
10.Market Segmentation by Type of Disease
10.1 Crohn’s disease
10.2 Ulcerative colitis
11.Global Crohn’s Disease Market
11.1 Market size and forecast
11.2 Crohn’s disease market in US
11.2.1 Market size and forecast
11.3 Crohn’s disease market in Japan
11.3.1 Market size and forecast
12.Global Ulcerative Colitis Market
12.1 Market size and forecast
13.Market Segmentation by Drug Class
14.Market Segmentation by Type of Molecule
14.1 Biologics
14.2 Small molecules
15.Market Segmentation by Dosage Form
15.1 Solid
15.2 Liquid
16.Market Segmentation by Route of Administration
16.1 Oral
16.2 Parenteral
17.Geographical Segmentation
17.1 Segmentation of global inflammatory market by geography
17.2 Segmentation of global Crohn’s disease and ulcerative colitis markets by geography
17.3 Segmentation of global Crohn’s disease market by geography
17.4 Segmentation of global ulcerative colitis market by geography
18.Key Leading Countries
18.1 Key leading countries 2014
18.2 Key leading countries 2019
18.3 US
18.4 Japan
19.Buying Criteria
20.Market Growth Drivers
21.Drivers and their Impact
22.Market Challenges
23.Impact of Drivers and Challenges
24.Market Trends
25.Trends and their Impact
26.Vendor Landscape
26.1 Competitive scenario
26.1.1 Key news
26.1.2 Mergers and acquisitions
26.2 Market share analysis 2014
26.2.1 Competitive assessment of top drugs for inflammatory bowel disease
26.2.2 AbbVie
26.2.3 Janssen Pharmaceuticals
26.2.4 Merck
26.2.5 Biogen Idec
26.2.6 UCB
26.2.7 Shire
26.3 Other and future prominent vendors
27.Key Vendor Analysis
27.1 AbbVie
27.1.1 Key facts
27.1.2 Business overview
27.1.3 Product segmentation by revenue 2013
27.1.4 Product segmentation by revenue 2012 and 2013
27.1.5 Sales by geography
27.1.6 Business strategy
27.1.7 Key developments
27.1.8 SWOT analysis
27.2 Biogen Idec
27.2.1 Key facts
27.2.2 Business overview
27.2.3 Business segmentation by revenue 2013
27.2.4 Geographical segmentation by revenue 2013
27.2.5 Business strategy
27.2.6 Key developments
27.2.7 SWOT analysis
27.3 Janssen Pharmaceuticals
27.3.1 Key facts
27.3.2 Business overview
27.3.3 Recent developments
27.3.4 SWOT analysis
27.4 Merck
27.4.1 Key facts
27.4.2 Business overview
27.4.3 Business segmentation by revenue 2013
27.4.4 Business segmentation by revenue 2012 and 2013
27.4.5 Sales by geography
27.4.6 Business strategy
27.4.7 Key developments
27.4.8 SWOT analysis
27.5 Shire
27.5.1 Key facts
27.5.2 Business overview
27.5.3 Geographical segmentation by revenue 2013
27.5.4 Business strategy
27.5.5 Recent developments
27.5.6 SWOT analysis
27.6 UCB
27.6.1 Key facts
27.6.2 Business overview
27.6.3 Product segmentation by revenue 2013
27.6.4 Product segmentation by revenue 2012 and 2013
27.6.5 Geographical segmentation by revenue 2013
27.6.6 Business strategy
27.6.7 Recent developments
27.6.8 SWOT analysis
28.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market research methodology
Exhibit 2: Challenges and drivers of global inflammatory bowel disease market
Exhibit 3: Overview of Crohn’s disease
Exhibit 4: Classification of Crohn’s disease
Exhibit 5: Expected number of global Crohn’s disease cases 2015-2022
Exhibit 6: Global variation in incidence rates for Crohn’s disease in 2012 (in %)
Exhibit 7: Prevalence of Crohn’s disease in US
Exhibit 8: Incidence of Crohn’s disease in US
Exhibit 9: Symptoms of Crohn’s disease
Exhibit 10: Crohn’s disease: diagnosis and testing
Exhibit 11: Crohn’s disease: treatment
Exhibit 12: Treatment landscape for Crohn’s disease
Exhibit 13: Crohn’s disease: treatment pathway
Exhibit 14: Ulcerative colitis: Symptoms
Exhibit 15: Diagnostic approach for ulcerative colitis
Exhibit 16: Treatment options for ulcerative colitis
Exhibit 17: Surgical procedures to treat ulcerative colitis
Exhibit 18: Crohn’s disease: pipeline portfolio
Exhibit 19: Crohn’s disease clinical trial by phase
Exhibit 20: Crohn’s disease clinical trial by status
Exhibit 21: Ulcerative colitis: pipeline portfolio
Exhibit 22: Snapshot of global inflammatory bowel disease market 2014
Exhibit 23: Global inflammatory bowel disease market 2014-2019 ($ million)
Exhibit 24: Inflammatory bowel disease market in US 2014-2019 ($ million)
Exhibit 25: Inflammatory bowel disease market in EU 2014-2019 ($ million)
Exhibit 26: Inflammatory bowel disease market in Japan 2014-2019 ($ million)
Exhibit 27: Segmentation of global inflammatory bowel disease market by type of disease
Exhibit 28: Segmentation of global inflammatory bowel disease market by type of disease 2014
Exhibit 29: Segmentation of global inflammatory bowel disease market by type of disease 2019
Exhibit 30: Revenue of global inflammatory bowel disease market 2014-2019 ($ million)
Exhibit 31: Snapshot of global Crohn’s disease market 2014
Exhibit 32: Global Crohn’s disease market 2014-2019 ($ million)
Exhibit 33: Crohn’s disease market in US 2014-2019 ($ million)
Exhibit 34: Crohn’s disease market in Japan 2014-2019 ($ million)
Exhibit 35: Snapshot of global ulcerative colitis market
Exhibit 36: Global ulcerative colitis market 2014-2019 ($ million)
Exhibit 37: Segmentation of global inflammatory bowel disease market by drug class
Exhibit 38: Benefits and risks of 5-ASA
Exhibit 39: Segmentation of global inflammatory bowel disease market by drug class 2014
Exhibit 40: Segmentation of global inflammatory bowel disease market by type of molecule
Exhibit 41: Segmentation of global inflammatory bowel disease market by type of molecule 2014
Exhibit 42: Segmentation of global inflammatory bowel disease market by dosage form
Exhibit 43: Segmentation of global inflammatory bowel disease market by dosage form 2014
Exhibit 44: Segmentation of global inflammatory bowel disease market by route of administration
Exhibit 45: Segmentation of global inflammatory bowel disease market by route of administration 2014
Exhibit 46: Segmentation of global inflammatory bowel disease market by geography 2014
Exhibit 47: Segmentation of global inflammatory bowel disease market by geography 2019
Exhibit 48: Segmentation of global Crohn’s disease market by geography 2014
Exhibit 49: Segmentation of global ulcerative colitis market by geography 2014
Exhibit 50: Major drivers of global inflammatory bowel disease market
Exhibit 51: Major challenges in global inflammatory bowel disease market
Exhibit 52: Major trends in global inflammatory bowel disease market
Exhibit 53: Ranking of vendors 2014
Exhibit 54: YoY revenue of top drugs for inflammatory bowel disease 2010-2014 ($ million)
Exhibit 55: Revenue share of top drugs for inflammatory bowel disease 2010-2014
Exhibit 56: AbbVie: product portfolio
Exhibit 57: YoY global revenue of Humira 2009-2014 ($ million)
Exhibit 58: YoY revenue of Humira in US 2009-2014 ($ million)
Exhibit 59: YoY international revenue of Humira (except US) 2009-2014 ($ million)
Exhibit 60: Revenue comparison of Humira 2009-2014 ($ million)
Exhibit 61: Janssen: product portfolio
Exhibit 62: YoY global revenue of Remicade 2009-2014 ($ million)
Exhibit 63: YoY global revenue of Simponi 2010-2014 ($ million)
Exhibit 64: Merck: product portfolio
Exhibit 65: YoY global revenue of Remicade 2009-2014 ($ million)
Exhibit 66: YoY global revenue of Simponi 2010-2014 ($ million)
Exhibit 67: Biogen Idec: product portfolio
Exhibit 68: YoY global revenue of Tysabri 2009-2014 ($ million)
Exhibit 69: YoY revenue of Tysabri in US 2009-2014 ($ million)
Exhibit 70: YoY revenue of Tysabri in ROW 2009-2014 ($ million)
Exhibit 71: Global revenue of Tysabri 2009-2014 ($ million)
Exhibit 72: UCB: product portfolio
Exhibit 73: YoY global revenue of Cimzia 2010-2014 ($ million)
Exhibit 74: Shire: product portfolio
Exhibit 75: YoY global revenue of Lialda 2010-2014 ($ million)
Exhibit 76: AbbVie: product segmentation by revenue 2013
Exhibit 77: AbbVie: product segmentation by revenue 2012 and 2013 ($ million)
Exhibit 78: AbbVie: sales by geography 2013
Exhibit 79: Biogen Idec: business segmentation by revenue 2013
Exhibit 80: Biogen Idec: geographical segmentation by revenue 2013
Exhibit 81: Merck: business segmentation by revenue 2013
Exhibit 82: Merck: business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 83: Merck: sales by geography 2013
Exhibit 84: Shire: geographical segmentation by revenue 2013
Exhibit 85: UCB: product segmentation by revenue 2013
Exhibit 86: UCB: product segmentation by revenue 2012 and 2013 ($ million)
Exhibit 87: UCB: geographical segmentation by revenue 2013
【レポート販売概要】
■ タイトル：炎症性腸疾患（IBD）治療薬の世界市場：クローン病、潰瘍性大腸炎■ 英文：Global Inflammatory Bowel Disease Market 2015-2019
■ 発行日：2015年4月15日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5692
■ 調査対象地域：グローバル
- 金属熱処理の世界市場2016-2020About the Metal Heat Treatment Market Metal heat treatment is a method used to change the physical and chemical properties of metals. Most metal components require thermal processing to change their metallurgical and physical properties to attain the desired engineering requirements for their intended use. Metal heat treatment involves the use of a vacuum furnace in which metals are heated to a pa …
- PET包装の世界市場2019-2023About this market Rising popularity of lightweight packaging to emerge as major trend in the market. Increase in R&D activities, to develop new lightweight packaging to reduce wastage and enhance end-user usability, is gaining momentum. Lightweight packaging is both cost-effective and recyclable in nature. For instance, glass packaging solution is heavy. It is cumbersome to transport products pack …
- パッケージ入りバスマティ米の世界市場2018-2022About Packaged Basmati Rice Basmati is a long-grain, aromatic rice grown in the specific geographical area of the Himalayan foothills of the Indian sub-continent. This variety of rice has extra-long slender grains that elongate at least twice of their original size and have a characteristic soft and fluffy texture upon cooking. Technavio’s analysts forecast the global packaged basmati rice market …
- Quicksilver Resources Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- キラル化学物質の世界市場の収益分析：製品別（実験装置、微生物学分析装置、試薬）、用途別（呼吸器系、血流系感染症、胃腸、性感染症、尿路感染症、歯周病）、セグメント予測The global clinical microbiology market was valued at USD 8.4 billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024. Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceutical, and clinical applications for investigation and diagnosis of various infectious diseases. The market is rapidly growing d …
- Bone Metastasis：グローバル臨床試験レビューH1, 2013Bone Metastasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2013" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as …
- 一般外科器具の世界市場分析：製品別（使い捨て外科用品、開放外科用器具、最小侵襲手術器具、ロボットおよびコンピュータ支援外科デバイス、接着防止製品）、用途別、セグメント予測、2013 – 2024The global general surgery devices market was valued at USD 7.0 billion in 2015 and is expected to reach a value of USD 17.5 billion by 2024, based on a new study by Grand View Research, Inc. The growth of the market is attributed to the increasing geriatric population base, government support and continual technological advancements launched by the key players. Demand for advanced devices is grow …
- 医療機器分析試験外注の世界市場分析：サービス別（抽出･浸出、物質特性、物理的試験、バイオバーデン試験、無菌試験）、地域別、セグメント予測、2014 – 2025The global medical device analytical testing outsourcing market is expected to reach USD 8.3 billion by 2025, according to a new report by Grand View Research, Inc. A large number of medical device companies outsource analytical testing operations to minimize business risks, hasten product market entry, and reduce costs. These lead to significant rise in expenditure levels and, therefore, medical …
- バイオガスの世界市場2019-2023About this market The increasing rate of urbanization and population growth, which in turn, is leading to the higher consumption of goods and energy. Moreover, waste generation increases with the economic development of any particular region. The increase in the costs associated with the collection and treatment of these wastes is expected to be most drastic in low-income countries as it will be m …
- Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust GrowthMonoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth Summary GBI Research has released the pharmaceutical report “Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth”. The current market for breast cancer consists of five monoclonal Antibodies (mAbs), …
- 医療レポート：Dry Eye Syndrome-疫学予測（～2022）EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022 Summary Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. It results in symptoms of discomfort such as visual disturbance and tear film instability (DEWS, 2007). Middle-aged and older adults are th …
- ランジェリー（女性用下着）通販の世界市場About Lingerie Lingerie is a term used for women's innerwear. It originated from the French word “linge” for linen. Though in French the term is used for both male and female undergarments, in English it is solely used for women innerwear. The fabric used for manufacturing lingerie is primarily nylon, satin, silk, polyester, and laces. The term lingerie is predominantly used on behalf of undergarm …
- 光触媒ナノコーティングの世界市場Photocatalytic self-cleaning coatings are a significant market for nanoparticulate titanium dioxide (TiO2). Nano-TiO2 surfaces (coated with 10-20nm layer of TiO2) are commercially available and have been used in (mainly in the Japanese and European markets) in water and air purification, self-cleaning glass, concrete products and a variety of coatings applications. These coatings greatly benefit b …
- インドの水産飼料市場動向（～2022）The Indian subcontinent, with a rich biodiversity of fish species, has emerged as an important aquaculture country, particularly in the fresh water environment. As India is the second largest producer of fish, it provides an immense opportunity for aquafeed manufacturers to tap the growing demand for commercial aquafeed. Moreover, farmers are shifting from traditional ways of feeding aquatic speci …
- レベルセンサー（液面センサー）のグローバル市場動向（2013 – 2020）Industries use several different types of sensors to detect levels of fluids which helps to stop overflows and spill over of the fluid. Different type of level sensing technologies are used according to various applications fields such as consumer, automotive, petrochemicals, water & wastewater management, chemicals, transportation, industrial, power and manufacturing sector, and so on. Global lev …
